FindTrial
Sign In

A study to assess the efficacy of Dexamethasone as an adjuvant in ultrasound guided cervical plexus block using Bupivacaine 0.25% in patients undergoing thyroid surgery under general anesthesia

A study to evaluate the efficacy of Dexamethasone as an adjuvant in ultrasound guided cervical plexus block using Bupivacaine 0.25% in patients undergoing thyroid surgeries under entropy guided general Anesthesia- A randomised control study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032612
Enrollment
80
Registered
2021-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Bupivacaine 0.25%: 20ml Bupivacaine 0.25% using ultrasound guided bilateral superficial cervical plexus block before general Anesthesia Control Intervention1: Bupivacaine 0.25% and dexa

Sponsors

Dr Archana M
Lead Sponsor
Dr Satish Kumar M N
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who have given informed written consent 2. Patients with ASA grade 1 and 2 3. Patients ages 18-60years of either sex 4. Patients scheduled for elective thyroid surgeries lasting for 60 to 150 minutes

Exclusion criteria

Exclusion criteria: 1. Patients not willing to give informed consent 2. Patients with allergy to Bupivacaine 3. Patients diagnosed with vocal cord palsy by preoperative indirect laryngoscopes 4. Patients with thyroid mass extending retrosternalily, any gross compression or deviation of trachea 5. Patients scheduled for extensive radical neck dissection 6. Patients with electrolyte abnormalities, hepatic or renal insufficiency, coagulation disorder, hypertension or cardiac disorders 7. Pregnant and breast feeding women

Design outcomes

Primary

MeasureTime frame
Hemodynamic stabilityTimepoint: Hemodynamic stability—

Secondary

MeasureTime frame
AnalgesiaTimepoint: Post operative period;Isoflurane consumptionTimepoint: Intraoperative period;Other adverse effectsTimepoint: Post operative period—

Countries

India

Contacts

Public ContactDr Satish Kumar M N

Bangalore medical college and research institute

drsats007@gmail.com9916207210

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026